Progress towards a glycoconjugate vaccine against Group A Streptococcus. (2023)
Attributed to:
Development and application of an Advanced Glycan Production Platform
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-023-00639-5
PubMed Identifier: 36977677
Publication URI: http://europepmc.org/abstract/MED/36977677
Type: Journal Article/Review
Volume: 8
Parent Publication: NPJ vaccines
Issue: 1
ISSN: 2059-0105